2 enrolling by invitation. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Enrolling by invitation 2 |
Follow Eczema: new trials by email Literature Review of Eczema trials Research Report on Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis IMG-007 - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 2 | Enrolling by invitation | Inmagene LLC | 400 | 2026-06-05 | 2026-07-29 |
| Efficacy of Topical Cannabidiol for Eczema Cannabidiol (CBD), Triamcinolone (TAC) 0.1% cream - Chronic Pruritus, Eczema | Phase 2 | Enrolling by invitation | Khon Kaen University | 60 | 2025-05-01 | 2026-08-04 |
Dermatitis, Atopic (2) · Dermatitis (1) · Immune System Diseases (1) · Skin Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Skin Diseases, Eczematous (2) · Skin Diseases, Genetic (2) · Skin and Connective Tissue Diseases (2) · Dermatitis (1) · Immune System Diseases (1) · Skin Diseases (1)
Cannabidiol (1) · Triamcinolone (1)
Inmagene LLC (1) · Khon Kaen University (1)
Canada (1) · Thailand (1) · United States (1)